Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-04-29

Clinical Trial Update: The Impact of Bright Classroom on Myopia [NA]

View source ↗

Summary

The clinical trial NCT05156190 evaluating the impact of Bright Classroom on myopia has been withdrawn, with Queen's University Belfast listed as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Queen's University, Belfast | Conditions: Myopia | NA | Status: WITHDRAWN